Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases. Focused on the IL-7 pathway and complement system, Q32 Bio is addressing dysregulation to help patients take back control of their lives in diseases with few to no treatment options, or those diseases where current therapeutics provide inadequate relief.
Location: United States, Massachusetts, Cambridge
Member count: 11-50
Total raised: $106M
Founded date: 2017
Investors 3
| Date | Name | Website |
| - | OrbiMed | orbimed.co... |
| - | Atlas Vent... | atlasventu... |
| 13.05.2022 | Abingworth... | abingworth... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 29.10.2020 | Series B | $60M | - | finsmes.co... |
| 27.05.2020 | Series A | $46M | - | news.crunc... |
Mentions in press and media 12
| Date | Title | Description | Category | Author | Source |
| 07.07.2021 | Q32 Bio Ap... | CAMBRIDGE, Mass., July 7, 20... | - | - | prnewswire... |
| 04.11.2020 | Q32 Bio Ra... | Q32 Bio, a Cambridge, Mass.-ba... | USA | - | finsmes.co... |
| 30.10.2020 | Q32 Bio se... | - | - | - | vcbay.news... |
| 29.10.2020 | Q32 Bio gr... | For a company that launched ... | Financing | Amber Tong | endpts.com... |
| 29.10.2020 | Q32 Bio Sc... | CAMBRIDGE, MA, Q32 Bio, a bi... | - | - | vcnewsdail... |
| 29.10.2020 | Congratula... | - | - | - | abingworth... |
| 29.10.2020 | Q32 Bio Cl... | CAMBRIDGE, Mass., Oct. 29, 2... | - | - | prnewswire... |
| 29.10.2020 | Q32 Bio Cl... | Q32 Bio, a biotechnology compa... | - | - | citybizlis... |
| 29.05.2020 | StartUPDAT... | Bright.md announced that it cl... | - | - | medcitynew... |
| 27.05.2020 | Q32 Bio Ra... | Q32 Bio, a Cambridge, Massachu... | USA | - | finsmes.co... |
Show more